The Ensign Group, Inc. (NASDAQ:ENSG) Given Average Recommendation of “Moderate Buy” by Brokerages

The Ensign Group, Inc. (NASDAQ:ENSG) has been assigned a consensus rating of “Moderate Buy” from the six analysts that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $216.75.

A number of equities research analysts have recently issued reports on ENSG shares. Royal Bank Of Canada reiterated an “outperform” rating on shares of The Ensign Group in a research report on Tuesday, June 9th. Weiss Ratings downgraded The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Finally, Zacks Research cut The Ensign Group from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th.

The Ensign Group Price Performance

Shares of NASDAQ:ENSG opened at $163.05 on Friday. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.06. The company has a market cap of $9.53 billion, a P/E ratio of 26.56, a PEG ratio of 1.62 and a beta of 0.68. The Ensign Group has a 52 week low of $134.79 and a 52 week high of $218.00. The company has a 50-day moving average price of $171.64 and a 200 day moving average price of $184.97.

The Ensign Group (NASDAQ:ENSG) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.79 by $0.06. The firm had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.40 billion. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The firm’s revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.52 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Research analysts predict that The Ensign Group will post 6.82 earnings per share for the current year.

The Ensign Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Tuesday, June 30th. The Ensign Group’s dividend payout ratio is 4.23%.

Insiders Place Their Bets

In other The Ensign Group news, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total value of $114,996.00. Following the completion of the transaction, the director directly owned 21,352 shares in the company, valued at approximately $3,507,706.56. The trade was a 3.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the business’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $199.97, for a total value of $78,388.24. Following the completion of the transaction, the director owned 9,295 shares of the company’s stock, valued at $1,858,721.15. This trade represents a 4.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 2,592 shares of company stock worth $478,246. 4.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in The Ensign Group by 9.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after acquiring an additional 14,590 shares during the last quarter. Geneos Wealth Management Inc. raised its holdings in The Ensign Group by 150.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after acquiring an additional 230 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in The Ensign Group by 65.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after acquiring an additional 213 shares during the last quarter. Amundi raised its holdings in The Ensign Group by 480,216.7% in the 2nd quarter. Amundi now owns 57,638 shares of the company’s stock valued at $8,583,000 after acquiring an additional 57,626 shares during the last quarter. Finally, Brown Advisory Inc. raised its holdings in The Ensign Group by 26.1% in the 2nd quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock valued at $314,000 after acquiring an additional 421 shares during the last quarter. 96.12% of the stock is currently owned by institutional investors and hedge funds.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.